Akari Therapeutics PLC logo

Akari Therapeutics PLC - ADR

NAS:AKTX (USA)   ADR
$ 1.12 -0.02 (-1.75%) 11:08 PM EST
At Loss
Market Cap:
$ 27.73M
Enterprise V:
$ 26.48M
Volume:
42.23K
Avg Vol (2M):
37.92K
Trade In:
Volume:
42.23K
At Loss
Avg Vol (2M):
37.92K

AKTX Stock Institutional Ownership and Insider Ownership - Akari Therapeutics PLC

24.76
(Mil)
Shares Outstanding
1.48%
0.18 (Mil)
Institutional Ownership
20.45%
4967.06 (Mil)
Insider Ownership 1
38.10%
9.4343 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Akari Therapeutics PLC. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Akari Therapeutics PLC. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders